Michel MF - Search Results

1

Endemic acinetobacter in intensive care units: epidemiology and clinical impact.

Dijkshoorn L, van Dalen R, van Ooyen A, Bijl D, Tjernberg I, Michel MF, Horrevorts AM. Dijkshoorn L, et al. Among authors: michel mf. J Clin Pathol. 1993 Jun;46(6):533-6. doi: 10.1136/jcp.46.6.533. J Clin Pathol. 1993. PMID: 8331175 Free PMC article.

2

Use of protein profiles to identify Acinetobacter calcoaceticus in a respiratory care unit.

Dijkshoorn L, Wubbels JL, Beunders AJ, Degener JE, Boks AL, Michel MF. Dijkshoorn L, et al. Among authors: michel mf. J Clin Pathol. 1989 Aug;42(8):853-7. doi: 10.1136/jcp.42.8.853. J Clin Pathol. 1989. PMID: 2768524 Free PMC article.

3

Comparison of clinical Acinetobacter strains using a carbon source growth assay.

Dijkshoorn L, Van Ooyen A, Hop WC, Theuns M, Michel MF. Dijkshoorn L, et al. Among authors: michel mf. Epidemiol Infect. 1990 Jun;104(3):443-53. doi: 10.1017/s0950268800047452. Epidemiol Infect. 1990. PMID: 2347384 Free PMC article.

4

Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis.

Horrevorts AM, Borst J, Puyk RJ, De Ridder R, Dzoljicdanilovic G, Degener JE, Kerrebijn KF, Michel MF. Horrevorts AM, et al. Among authors: michel mf. J Med Microbiol. 1990 Feb;31(2):119-24. doi: 10.1099/00222615-31-2-119. J Med Microbiol. 1990. PMID: 2106033

5

Typing of Acinetobacter calcoaceticus strains isolated from hospital patients by cell envelope protein profiles.

Dijkshoorn L, Van Vianen W, Degener JE, Michel MF. Dijkshoorn L, et al. Among authors: michel mf. Epidemiol Infect. 1987 Dec;99(3):659-67. doi: 10.1017/s0950268800066516. Epidemiol Infect. 1987. PMID: 3428372 Free PMC article.

6

Cell envelope protein profiles of Acinetobacter calcoaceticus strains isolated in hospitals.

Dijkshoorn L, Michel MF, Degener JE. Dijkshoorn L, et al. Among authors: michel mf. J Med Microbiol. 1987 Jun;23(4):313-9. doi: 10.1099/00222615-23-4-313. J Med Microbiol. 1987. PMID: 3585964

7

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

Mouton JW, Horrevorts AM, Mulder PG, Prens EP, Michel MF. Mouton JW, et al. Among authors: michel mf. Antimicrob Agents Chemother. 1990 Dec;34(12):2307-11. doi: 10.1128/AAC.34.12.2307. Antimicrob Agents Chemother. 1990. PMID: 2088186 Free PMC article.

8

Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.

Horrevorts AM, Driessen OM, Michel MF, Kerrebijn KF. Horrevorts AM, et al. Among authors: michel mf. Chest. 1988 Aug;94(2 Suppl):120S-125S. Chest. 1988. PMID: 3293937 Review.

9

Tobramycin in patients with cystic fibrosis. Adjustment in dosing interval for effective treatment.

Horrevorts AM, de Witte J, Degener JE, Dzoljic-Danilovic G, Hop WC, Driessen O, Michel MF, Kerrebijn KF. Horrevorts AM, et al. Among authors: michel mf. Chest. 1987 Nov;92(5):844-8. doi: 10.1378/chest.92.5.844. Chest. 1987. PMID: 3665599

10

Antibiotic interaction: interpretation of fractional inhibitory and fractional bactericidal concentration indices.

Horrevorts AM, Michel MF, Kerrebijn KF. Horrevorts AM, et al. Among authors: michel mf. Eur J Clin Microbiol. 1987 Aug;6(4):502-3. doi: 10.1007/BF02013128. Eur J Clin Microbiol. 1987. PMID: 3665908 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters